Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00410618|
Recruitment Status : Completed
First Posted : December 13, 2006
Last Update Posted : December 3, 2015
RATIONALE: Learning about the long-term effects of chemotherapy and radiation therapy on brain function may help doctors plan cancer treatments.
PURPOSE: This clinical trial is looking at the neurological effects of chemotherapy and radiation therapy in patients with colon cancer.
|Condition or disease||Intervention/treatment|
|Cognitive/Functional Effects Colorectal Cancer Long-term Effects Secondary to Cancer Therapy in Adults||Procedure: cognitive assessment Procedure: magnetic resonance imaging Procedure: management of therapy complications|
- Identify the nature and long-term ramifications of CNS injury as a result of cancer treatment in patients with colon cancer.
- Analyze differences in cognitive measures and MRI data in these patients.
- Correlate MRI measures with cognitive performance in these patients.
OUTLINE: Patients undergo cognitive performance assessment and MRI.
PROJECTED ACCRUAL: A total of 42 patients will be accrued for this study.
|Study Type :||Observational|
|Estimated Enrollment :||42 participants|
|Official Title:||Neurological Effects of Chemotherapy and Radiation Treatment: Colon Cancer|
|Study Start Date :||April 2003|
|Actual Primary Completion Date :||August 2006|
|Actual Study Completion Date :||August 2006|
- Nature and long-term ramifications of CNS injury as a result of cancer treatment
- Differences in cognitive measures and MRI data
- Relationship between MRI measures and cognitive performance
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00410618
|United States, Arizona|
|Arizona Cancer Center at University of Arizona Health Sciences Center|
|Tucson, Arizona, United States, 85724-5024|
|Study Chair:||Sheryl Reminger, MD||University of Arizona|